Related Experiment Video

Updated: Jul 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

[Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy]

W M Brückl1, S Lampert, S Zirlik

  • 1Medizinische Klinik 1, Universitätsklinikum Erlangen. wolfgang.brueckl@uk-erlangen.de

Pneumologie (Stuttgart, Germany)
|October 20, 2007
PubMed

Insights

Small-cell lung cancer (SCLC) is aggressive and often relapses after chemotherapy. New research into molecular mechanisms and targeted therapies like antibodies and vaccines offers hope for improved SCLC treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Small-cell lung cancer (SCLC) represents up to 20% of all lung cancers.
  • SCLC is characterized by its aggressive nature and early relapse rates post-chemotherapy.
  • Despite decades of research, patient prognosis for SCLC remains poor.

Purpose:

  • To review the current understanding of molecular mechanisms and genetic factors in SCLC.
  • To describe the diagnostic and prognostic value of relevant genes in SCLC.
  • To present an overview of ongoing clinical studies (Phase I/II) for SCLC treatment.

Summary:

  • This review details the molecular underpinnings of SCLC, emphasizing gene functions, and their diagnostic/prognostic significance.
  • It explores emerging therapeutic strategies including antibodies, small molecules, and vaccines based on molecular insights.
  • Current Phase I and II clinical trials for SCLC treatment are discussed, highlighting novel therapeutic approaches.

Impact:

  • Advances in understanding SCLC molecular mechanisms can guide the development of more effective therapies.
  • Identifying diagnostic and prognostic biomarkers may improve patient stratification and treatment selection.
  • Translational research into novel agents like antibodies and vaccines holds potential for improved SCLC patient outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.